Trust Co. of Toledo NA OH Sells 1,109 Shares of CME Group Inc. (NASDAQ:CME)

Trust Co. of Toledo NA OH decreased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 12.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,805 shares of the financial services provider's stock after selling 1,109 shares during the period. Trust Co. of Toledo NA OH's holdings in CME Group were worth $2,071,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. New Age Alpha Advisors LLC boosted its position in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 43 shares during the period. Knuff & Co LLC bought a new position in shares of CME Group during the fourth quarter valued at about $33,000. Banque Transatlantique SA bought a new position in CME Group during the 4th quarter worth approximately $35,000. Whipplewood Advisors LLC bought a new position in shares of CME Group in the fourth quarter worth approximately $37,000. Finally, United Community Bank purchased a new position in shares of CME Group in the fourth quarter valued at about $37,000. Institutional investors own 87.75% of the company's stock.

Insider Buying and Selling

In related news, General Counsel Jonathan L. Marcus sold 390 shares of CME Group stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the transaction, the general counsel now directly owns 6,708 shares of the company's stock, valued at approximately $1,861,470. The trade was a 5.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director now owns 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,400 shares of company stock worth $3,680,610. Corporate insiders own 0.30% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CME. Royal Bank of Canada reissued a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. JPMorgan Chase & Co. decreased their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Piper Sandler lifted their price target on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Bank of America upped their price objective on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Finally, UBS Group raised their price target on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, CME Group has an average rating of "Hold" and a consensus price target of $258.20.

CME Group Stock Performance

Shares of CME stock traded down $1.46 during trading hours on Friday, reaching $269.50. 1,576,352 shares of the company traded hands, compared to its average volume of 2,200,731. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $290.79. The company has a market cap of $97.12 billion, a P/E ratio of 27.87, a P/E/G ratio of 6.76 and a beta of 0.45. The firm has a 50-day moving average price of $272.73 and a 200 day moving average price of $254.39. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period last year, the firm earned $2.50 earnings per share. The business's quarterly revenue was up 10.4% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's payout ratio is currently 50.30%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.